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Background/introduction
Stem cell therapy is a promising strategy to treat neurode-
generative diseases, including Alzheimer’s and Parkinson’s
diseases. However, for stem cell therapy to be considered
for clinical use, new delivery methods need to be devel-
oped. We have used focused ultrasound (FUS) as a
method to induce transient opening of the blood-brain
barrier (BBB) to promote the passage of therapeutic stem
cells into the brain.
Methods
As a proof of principle study to demonstrate the applica-
tion of this therapeutic strategy for Parkinson’s disease, we
targeted the striatum using magnetic resonance imaging
(MRI) for BBB opening. Definity microbubble contrast
agent was injected intravenously at the onset of FUS appli-
cation using a 558 kHz transducer (~0.3 MPa estimated
in situ pressure, 10 ms bursts, 1 Hz pulse repetition
frequency, 120 s total exposure duration).
Results and conclusions
During FUS application, neural stem cells expressing
green-fluorescent protein (GFP) and labeled with super-
paramagnetic iron oxide (SPIO) were injected into the car-
otid artery. Follow up contrast enhanced MR imaging
confirmed the opening of the BBB and at 24 hrs, MRI was
used to detect the SPIO labeled stem cells in the region of
interest. After sacrifice, GFP expressing cells were present
in the targeted regions of the brain and expressed a neuro-
nal phenotype indicative of their survival post-delivery
through the BBB. Histological analysis showed some red
blood cell extravasation but there was no evidence of
brain tissue damage due to FUS treatment. Together,
these data suggest that FUS is an efficient method for
delivery of stem cells to the brain and may be the key to
reducing the risks of cell transplantation helping to move
stem cell therapy forward.
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